Gopa Iyer, Hiromichi Ebi, Natalie Cook, Xin Gao, Shigehisa Kitano, Nobuaki Matsubara, Melissa A Reimers, Arlene O. Siefker-Radtke, Miso Kim, Matthew D. Galsky, Debbie GJ Robbrecht, Jun Guo, Bernhard J. Eigl, Clare Schaverien, Brent Butts, Eunice Yuen, Sylwia Szymczak, Xiang Zhao, Ryan C Widau, Alexandra Drakaki. "A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with FGFR3 alterations: Initial results from FORAGER-1.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.662